NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 62.30% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-08-04
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2026-03-31 was 77.10%, a 0.52% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-03-31 was 77.50%, a 5.30% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 73.60%, a 2.52% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-03-31 was 75.50%, a 1.31% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 74.40%, a 1.33% decline from fiscal 2023.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 75.40%, a 1.31% decline from fiscal 2022.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 76.40%, a 2.41% increase from fiscal 2021.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2021 was 74.60%, a 11.34% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 62.30% 10-Q · filed 2026-08-04 | |||||
| 2026-03-31 | 77.10% 10-Q · filed 2026-05-06 | |||||
| 2025-09-30 | 78.00% 10-Q · filed 2025-11-04 | |||||
| 2025-06-30 | 78.00% 10-Q · filed 2025-08-06 | |||||
| 2025-03-31 | 77.50% 10-Q · filed 2025-05-07 | |||||
| 2024-12-31 | 74.40% 10-K · filed 2025-03-04 | |||||
| 2024-09-30 | 74.30% 10-Q · filed 2024-10-31 | |||||
| 2024-06-30 | 74.20% 10-Q · filed 2024-08-07 | |||||
| 2024-03-31 | 73.60% 10-Q · filed 2024-05-08 | |||||
| 2023-12-31 | 75.40% 10-K · filed 2025-03-04 | |||||
| 2023-09-30 | 75.40% 10-Q · filed 2023-11-08 | |||||
| 2023-06-30 | 75.40% 10-Q · filed 2023-08-09 | |||||
| 2023-03-31 | 75.50% 10-Q · filed 2023-05-10 | |||||
| 2022-12-31 | 76.40% 10-K · filed 2024-03-06 | |||||
| 2022-09-30 | 76.50% 10-Q · filed 2022-11-02 | |||||
| 2022-06-30 | 76.00% 10-Q · filed 2022-08-10 | |||||
| 2022-03-31 | 76.50% 10-Q · filed 2022-05-12 | |||||
| 2021-12-31 | 74.60% 10-K · filed 2023-03-08 | 75.00% 10-K · filed 2022-03-14 | ||||
| 2021-09-30 | 74.40% 10-Q · filed 2021-11-03 | |||||
| 2021-06-30 | 74.20% 10-Q · filed 2021-08-03 | |||||
| 2021-03-31 | 73.00% 10-Q · filed 2021-05-06 | |||||
| 2020-12-31 | 67.00% 10-K · filed 2022-03-14 | |||||
| 2020-09-30 | 6600.00% 10-Q · filed 2020-11-04 | |||||
| 2020-06-30 | 6600.00% 10-Q · filed 2020-08-06 | |||||
| 2020-03-31 | 66.00% 10-Q · filed 2020-05-18 | |||||
| 2019-12-31 | 67.00% 10-K · filed 2021-03-12 | |||||
| 2019-09-30 | 67.00% 10-Q · filed 2019-11-12 | |||||
| 2019-06-30 | 67.00% 10-Q · filed 2019-08-07 | |||||
| 2019-03-31 | 67.00% 10-Q · filed 2019-05-09 | |||||
| 2018-12-31 | 69.00% 10-K · filed 2020-03-10 | |||||
| 2018-03-31 | 69.00% 10-Q · filed 2018-05-10 | |||||
| 2017-09-30 | 73.00% 10-Q · filed 2017-11-09 | |||||
| 2017-07-01 | 73.00% 10-Q · filed 2017-08-10 | |||||
| 2017-04-01 | 73.00% 10-Q · filed 2017-05-11 | |||||
| 2016-10-01 | 73.00% 10-Q · filed 2016-11-10 | |||||
| 2016-07-02 | 73.00% 10-Q · filed 2016-08-11 | |||||
| 2016-03-11 | 60.00% 10-Q · filed 2016-11-10 | |||||
| 2015-10-03 | 76.00% 10-Q · filed 2015-11-12 | |||||
| 2015-07-04 | 75.00% 10-Q · filed 2015-08-13 | |||||
| 2015-04-04 | 75.00% 10-Q · filed 2015-05-14 | |||||
| 2014-09-27 | 73.55% 10-Q · filed 2014-11-06 | |||||
| 2014-06-28 | 72.82% 10-Q · filed 2014-08-12 | |||||
| 2014-03-29 | 69.64% 10-Q · filed 2014-05-08 | |||||
| 2012-12-29 | 33.22% 10-K · filed 2013-03-29 | |||||
| 2011-12-31 | 31.56% 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |